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Skin Cancer Types and the Effectiveness of Mohs Surgery Against them
Andrew Brockman
Dr. Suzanne Byrd
Department of Biological Sciences

Abstract Description: Skin cancer is the number one form of cancer around the world today. It
affects people of all races and discriminates no one when it comes to how deadly it can become
when it metastasizes. As rates of skin cancer continue to increase year after year, research is
being conducted at a very high rate on possible treatments for this disease. Understanding the
three basic types of skin cancer, basal cell carcinoma, squamous cell carcinoma, and melanoma
gives a wary victim of skin cancer a guide for what they are dealing with as they progress
through possible treatment. There are a variety of types of treatments in modern medicine, many
of them being experimental and relying on fresh research. While new research is being
introduced at a high pace, the most effective type of treatment there is against non-melanoma
skin cancer is Mohs surgery, a type of surgical excision developed in the 1930s. This surgery has
been the foundation of effective treatment research against skin cancer for going on ninety years,
and still today is more cost effective, less time consuming, and produces better results than any
type of modern surgical excision for non-melanoma skin cancers.
Keywords: skin, cancer, basal, squamous, melanoma, carcinoma, Mohs, surgery, excision,
treatment
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Introduction
Skin cancer may develop from a variety of contributing factors, such as where a person
lives geographically, how much radiation from the sun or other sources they expose their skin to,
and even through genetic pathways. Many people wonder about which of these factors is the
most significant. Awareness of the causes of skin cancer are essential to the prevention of skin
cancer. Many people know the main cause is UV radiation from the sun, but many other factors
can play into the development of skin cancer as well. Smoking is well associated with lung
cancer, and it also plays a major role into developing cancer in the gums, brain, and skin. It is
important to make people aware of the severe consequences of ignoring the risk factors of skin
cancer. Non-melanoma skin cancers, which include squamous cell carcinoma and basal cell
carcinoma, are the most common malignancies in the United States, with approximately 3.5
million new cases diagnosed each year (Kimmel 2016). Melanoma, although less common, is the
deadliest form of skin cancer. Nearly 60,000 people are diagnosed and about 8,600 people die
from melanoma each year (Babbin 2015).
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Figure 1: Average Death Rate from Advanced Melanoma in Different Age Groups from
Years 2015-2017 Worldwide. There is a significant rise in average number of deaths per
year with every 5-year increase in age group.

Overall, skin cancer is the most common form of cancer in the United States, and the
incidence is increasing. The burden of skin cancer can be reduced through prevention efforts.
Exposure to ultraviolet radiation via the sun is the most common and avoidable cause of skin
cancers. Most adults in the United States do not protect themselves from the sun, and prevalence
of at least one sunburn per year is over 50% (Babbin 2015).
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Figure 2: Experimental Overview of Skin Cancer Incidences and Mortality Rates in the
United States. Observes differences in effectiveness against race and gender race over fiveyear increments.

Sun protection behaviors, such as avoiding the sun, wearing protective clothing, and
wearing sunscreen, can be emphasized in interventions designed to increase sun protection.
The skin of the head and face is habitually exposed to sunlight and there may consequently be
ultraviolet (UV)-induced chronic damage such as solar elastosis, actinic keratosis and lentigo,
with possible consequent development of cutaneous squamous cell carcinoma, cutaneous basal
4

cell carcinoma and cutaneous melanoma (Brash 2008).

Figure 3: Geographical Map of Deaths from Advanced Melanoma in United States (20152017). Density significantly increases in the Southeastern region of the United States.

Cutaneous basal cell carcinoma is the most common cancer in White people. Cutaneous
is used in front of the cancer type because it is the technical term for the combination of all three
layers of skin, these being the epidermis, dermis, and subcutaneous layers (Feller 2016). It is
named with the prefix of cutaneous because the cells of basal cell carcinoma resemble the cells
of the basal cell layer of the epithelium. Cutaneous basal cell carcinoma affects mainly
chronically sun-exposed skin of the head and neck of fair complexioned older people (Donovan
5

2009). Both intermittent acute, and long-standing continual exposure to UV are high risk factors
for cutaneous basal cell carcinoma. It is a slow-growing cancer that if left untreated will invade
locally, but only rarely metastasizes. Black people are rarely affected. People with cutaneous
basal cell carcinoma are at increased risk for cutaneous squamous cell carcinoma and cutaneous
melanoma (Tlholoe 2015).
The Hedgehog (Hh) signaling pathway was first identified in the common fruit fly. It is a
highly conserved evolutionary pathway of signal transmission from the cell membrane to the
nucleus. The Hh signaling pathway plays an important role in the embryonic development. It
exerts its biological effects through a signaling cascade that culminates in a change of balance
between activator and repressor forms of glioma-associated oncogene (Gli) transcription factors
(Skoda 2018). Dysregulation in the hedgehog intracellular signaling pathway is implicated in the
pathogenesis of cutaneous basal cell carcinoma and is thought to be an early genetic factor in its
tumorigenesis. The hedgehog signaling pathway plays an essential role in organogenesis’
development of different organs throughout the body, and later, postnatally, in regulating
proliferation and differentiation of keratinocyte stem cells, and in the development of hair
follicles and sebaceous glands (Skoda 2018). In the hedgehog signaling pathway, patch 1
(PTCH1) functions as a tumor suppressor gene, inhibiting the activity of the proto-oncogene,
smoothened (SMO) (Wong 2014). Signaling by SMO results in activation of transcription of
hedgehog target genes, eliciting mitogenic responses with increased proliferation of keratinocyte
stem cells, which produce keratin, a fibral structural protein that is a key component in the
makeup of hair, nails, and the outermost layer of skin (Wong 2014). Clonal expansion of
dysregulated cells within the keratinocytes stem cell niche is favored by loss-of-function
mutation in PTCH1 that allows upregulated activity of SMO, and by gain of function mutations
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in the SMO gene that render SMO protein resistant to inhibition by PTCH1. These promote
escape of cancer precursor cells from the niche to colonize other cellular compartments in the
skin, ultimately giving rise to a basal cell carcinoma (Brash 2008).

Figure 4: Summary of Hedgehog Signaling Pathway. Indicates the process that the
hedgehog pathway helps conduct, leading to eventual transcription of DNA. Full ability of
the pathway to lead to transcription depends on where the signal transmission is initiated.

The molecular alterations in the hedgehog signaling pathway may be of germline origin
or may occur postnatally subsequent to UV-induced DNA damage, or rarely may arise
spontaneously. Keratinocytes which show dysregulated expression of the hedgehog signaling
pathway fail to undergo cell-cycle arrest in response to the p21 cell cycle inhibitor, and thus have
enhanced proliferative capacity. It has been reported that most cases of cutaneous basal cell
carcinomas that arise spontaneously show loss of function of PCTH1 and a minority show
enhanced function of SMO (Carucci 2008). About half of all cases of sporadic basal cell
carcinoma also show mutations in the p53 tumor suppressor gene, but these seem to be late
genetic events in the tumorigenesis of cutaneous basal cell carcinoma, which are related to its
progression. Taking advantage of the inhibition of the hedgehog signaling pathway as a mean of
7

treatment of cutaneous basal cell carcinoma of the skin has become possible through the use of
an inhibitor, vismodegib, and other hedgehog pathway antagonists (Wong 2014).

Three Types of Skin Cancer
Cutaneous basal cell carcinoma requires a specific stromal environment to maintain its
morphological characteristics. Key regulators of the biological behavior of cutaneous basal cell
carcinoma appear to be stromal fibroblasts and myofibroblasts. Cutaneous basal cell carcinoma
cells express bone morphogenetic protein (BMP) 2 and 4, while GREMLIN 1, a BMP
antagonist, is highly expressed in the stroma of the tumor but not in the dermis underlying
normal keratinocytes (Boehnke 2012). GREMLIN 1 counteracts the growth-inhibitory effect of
BMPs and is therefore assumed to be an important agent supporting cutaneous basal cell
carcinoma cell proliferation and survival. Matrix metalloproteinase expressed in the stroma of
cutaneous basal cell carcinoma also plays an important role in regulating growth and other
functions of cutaneous basal cell carcinoma cells. It is probable that cutaneous basal cell
carcinoma tumorigenesis depends substantially on specific factors produced by stroma damaged
by UV, but on the rare occasions when cutaneous basal cell carcinomas occur at sites that are not
exposed to sunlight, other biological factors drive its initiation and progression (Boehnke 2012).
Although UV-radiation is a primary etiological factor for cutaneous basal cell carcinoma,
the mechanism whereby exposure to UV triggers cutaneous basal cell carcinoma is complex and
the details are as yet unknown (Epstein 2008). The development of cutaneous basal cell
carcinoma at sites not exposed to UV is unexplained. Cutaneous basal cell carcinoma usually
develops at sites continually exposed to UV which explains why basal cell carcinoma so
frequently affects the skin of the head and face. Reduced functional activity of genes regulating
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repair of DNA damaged by UV may be a modifying factor in the pathogenesis of cutaneous
basal cell carcinoma (Feller 2010). In support of this, subjects with the genetic condition,
xeroderma pigmentosum in whom there are high-penetrance germline mutations in genes
encoding proteins involved in the mechanism of nucleotide excision-repair are at great risk of
developing multiple and recurrent cutaneous basal cell carcinomas at a young age. In contrast to
subjects not affected by basal cell carcinoma, those who do have basal cell carcinoma show
reduced clearance of mutagenic photoproducts from UV-induced DNA lesions of sunlight
exposed skin, probably owing to low-penetrance genetic polymorphisms of specific genes
encoding enzymes involved in breaking down reactive oxygen species and DNA repair
(Radiespiel-Troger 2009).
Cutaneous squamous cell carcinoma originates from stem/progenitor cells of the basal
cell layer of the epidermis and cutaneous basal cell carcinoma from either the bulge region of a
hair follicle, which is rich in keratinocyte stem cells, or from stem/progenitor cells of the basal
cell layer of the epidermis. While the origin of melanoma cells is unknown, it has been proposed
that cutaneous melanoma precursor cells may arise either from dedifferentiated melanocytes or
from melanocyte progenitors in the bulge region of hair follicles, or from neural crest-derived
Schwann cell precursors (Tlholoe 2015).
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Figure 5: Examples of Squamous Cell Carcinoma. These photos represent advanced stages
of squamous cell carcinoma, and this is when a person with the disease is more likely to
notice the tumor.

Cutaneous squamous cell carcinoma of the skin is associated with frequent moderate
chronic UV exposure, and is often preceded by premalignant actinic keratosis or by Bowen
disease. On the other hand, cutaneous basal cell carcinoma is usually associated with
intermittent, infrequent, intense UV exposure and almost invariably arises de novo, which means
it is typically the first type of cancer that a patient has developed (Grossman 2008). Cutaneous
melanoma can also arise de novo after intermittent, infrequent, intense UV exposure, but there is
evidence that as many as 30 % of cases evolve from pre-existing sites of melanotic pigmentation,
whether or not they have actually been exposed to UV (Grossman 2008).
Both cutaneous squamous cell carcinoma and melanoma are very likely to metastasize
whereas cutaneous basal cell carcinoma very seldom does. Even in the absence of exposure to
10

UV, squamous cell carcinoma is occasionally associated with non-healing wounds or scarring, or
with chronic lesions which are, or have been preceded by chronic immuno-inflammatory
processes. This is not the case with cutaneous basal cell carcinoma or cutaneous melanoma.

Figure 6: MC1R Receptor Effect on Different Signaling Pathways. This diagram
thoroughly outlines the different chemical signaling pathways that MC1R has an effect
upon.
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Cutaneous squamous cell carcinoma, basal cell carcinoma and melanoma more
frequently affect elderly, red haired, blue eyed and fair complexioned persons, and it has been
consistently demonstrated that variants of the highly polymorphic melanocortin 1 receptor
(MC1R) gene are associated with increased risk of these malignancies (Scherer 2010). The
pathogenesis of cutaneous squamous cell carcinoma is associated with multiple local genetic
alterations that may bring about dysregulation of the cell cycle, of apoptosis, of DNA repair, of
cellular differentiation, of telomerase activity with evasion of cellular senescence, and of
expression of the enzyme cyclo-oxygenase 2 (COX-2) (Hoban 2002). In contrast, cutaneous
basal cell carcinoma is primarily driven by genetic mutations causing uncontrolled activation of
the hedgehog intracellular pathway leading to enhanced proliferative capacity of basal cells, and
by molecular alterations in the p53 tumor-suppressor gene. Most cases of cutaneous basal cell
carcinoma occur sporadically, but they may also occur as a manifestation of the rare heritable
basal cell nevus syndrome in association with germline molecular aberrations of the hedgehog
intracellular signaling pathway (Epstein 2008).
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Figure 7: Outline of p-53 Tumor Suppressor Gene Pathway. This diagram shows the
importance that p53 can have on different cellular pathways throughout the human body.
Melanomas of the skin of the head and face are usually of the lentigo maligna type,
which is commonly associated with frequent, moderate chronic UV exposure. This is in contrast
to melanomas of the trunk, for example, which are associated with intermittent, acute UV
exposure. Skin melanoma cells show molecular alterations of the RAS-BRAF-MEK-ERK
mitogen activated protein kinase (MAPK) signaling pathway, mediating uncontrolled
proliferation of the affected malignant melanocytes, genetic alterations in the CDKN2A gene
encoding the p16INK4A tumor suppressor protein, and MC1R genetic polymorphism (Riker
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2010). In 10-30% of cases, cutaneous melanoma arises from pre-existing melanotic
hyperpigmentation such as lentigo, freckles or pigmented naevi, or moles (Feller 2016). Despite
an established cause-and-effect relationship between the development of melanoma and exposure
to UV, genes with UV-induced ‘signature mutations’ are not common in melanoma. Thus, it is
evident that the etiopathogenesis of melanoma is complex, with UV playing a critical role, but
UV by itself does not necessarily cause melanoma. Indeed, in Black people, melanomas mainly
affect body sites that are not exposed to UV such as the soles of the feet and the palms of the
hands, or more commonly known as acral melanoma (Jhappan 2003).
Cutaneous melanoma is an aggressive skin tumor that can be classified into 4 main
subtypes: superficial spreading, nodular, lentigo maligna and acral melanoma. Lentigo maligna
melanoma typically affects long-term chronically UV-exposed skin of the head and face, where
other subtypes are relatively rare. The frequency of lentigo maligna melanoma increases with age
and peaks in the seventh to eighth decades of life. Lentigo maligna is an epithelial field of
atypical melanocytes which takes the form as an ill-defined brown macule which slowly expands
centrifugally (Andreassi 2011). When these atypical epithelial melanocytes breach the basement
membrane and invade the connective tissue, the lesion is referred to as lentigo maligna
melanoma. Cutaneous melanomas of the head and neck are less likely to arise in association with
pre-existing pigmented nevi than cutaneous melanomas of the trunk.
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Figure 8: Examples of Lentigo Maligna Melanoma. As stages of the skin cancer progress,
the melanoma typically gets darker as it seeps deeper into the dermis.

Many complex factors are implicated in the pathogenesis of cutaneous melanoma
including family history, phenotypic characteristics such as pale skin and red hair with
propensity to sunburn, many episodes of sunburn especially in youth, the presence of numerous
melanotic nevi or freckles, and pre-existing dysplastic nevi. Further factors are MC1R genetic
polymorphism, and perhaps other yet ill-defined environmental factors, but some MC1R variants
are associated with increased risk of cutaneous melanoma regardless of skin type and hair color
(Kennedy 2001).
Like cutaneous squamous cell carcinoma, lentigo maligna melanoma typically affects
chronically UV-exposed skin of the head and face, but the risk of other subtypes of melanoma is
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more related to intermittent, intense UV exposures. In contrast to malignant keratinocytes of
cutaneous squamous cell carcinoma that show UV-induced signature-mutations, these are rare in
cutaneous melanoma cells, and while mutations to tumor-suppressor gene p53 are frequent in
UV-induced squamous cell carcinoma, in UV-induced cutaneous melanoma they are not (Feller
2016). Cutaneous melanoma cells but not malignant keratinocytes show oncogenic mutations in
either NRAS or BRAF, which are specified genes in the body that deal with cell signaling and
cell growth (Feller 2016). Except for acral and mucosal melanomas, BRAF mutations are an
early genetic event of melanoma tumorigenesis and can be found in up to 60 % of frank
melanomas (Situm 2010). In contrast, in mucosal and acral melanomas there are gain-of-function
mutations in the cKit receptor thyrosine kinase. Inactivating mutations in the CDKN2A gene,
which encodes for p16INK4a tumor suppressor protein, poses a high risk for development of
cutaneous melanoma. Both BRAF and CDKN2A mutations in cutaneous melanoma cells are
characteristic of indirect UV-induced oxidative damage (Abdel-Malek 2009).
Cutaneous melanoma arising from melanocytes residing in the basal cell layer of the
epidermis usually shows one of two histopathological patterns. In one pattern there is a radial
growth phase characterized by proliferation of atypical melanocytes within the epidermis and by
small breaches of the basement membrane. In the other pattern there is a phase of ‘vertical’
growth which occurs once the basement membrane is breached and the melanoma starts to
invade the dermis in a nodular pattern without any significant preceding phase of radial growth
(Tlholoe 2015). A further third pattern of growth occurs when the cutaneous melanoma
originates from melanocyte precursors that reside in the dermis as a result of arrest in their
migration from the neural crest. In this case, epidermal melanocytes do not contribute to the
cutaneous melanoma and there is no evidence of invasive breaching of the basement membrane.
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Cutaneous melanoma is rare in Black persons, and when it occurs, it preferentially affects
body sites not habitually exposed to UV such as the sole of the foot, the palm of the hand and the
nail bed (acral melanomas). Although the dorsum of the hand is usually constantly exposed to
UV-radiation, for some obscure reasons it is only rarely affected by cutaneous melanoma.
Curiously, while the frequency of cutaneous basal cell carcinoma and cutaneous squamous cell
carcinoma is high in albino Blacks, cutaneous melanoma is rare in this population group. There
is evidence of loss of integrity of membranes of the melanosomes in melanoma cells with
consequent leakage of reactive oxygen species (ROS) and metabolic by-products of
melanogenesis that may be cytotoxic, genotoxic or mutagenic into the cytoplasm of melanoma
cells contributing to progressive DNA damage (Terenziani 2003). It is possible that the primary
alterations to DNA, favoring initial transformation of normal melanocytes and later promoting
malignant transformation of the initially transformed melanocytes may result from a similar loss
of integrity of the membranes of melanosomes within normal melanocytes (Gidanian 2008).

Potential Treatment Types
The Self-Efficacy Scale for Sun Protection was designed to assess an individual’s
confidence to protect oneself from sun exposure (Babbin 2015). Variations of this measure have
been utilized in multiple population-based interventions that have demonstrated effectiveness.
Assessments of factorial invariance and internal consistency suggest that the Self-Efficacy Scale
for Sun Protection is a reliable and valid instrument. It can be used across a full range of adult
participants varying by age, educational level, skin tone, gender, ethnicity, race, and stage
attributes. This measure is used to determine a person’s susceptibility to skin cancer.
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Figure 9: Self-Efficacy Effectiveness Ratios of Different Treatments. These ratios represent
the effectiveness ratio of these preventative measures on a 1.00 scale.
Skin is the largest human organ, our protection against various environmental assaults
and noxious agents. Accumulation of damage to this organ may lead to the formation of skin
cancers, including both melanoma and non-melanoma skin cancers. A safer, affordable, and
more effective strategy for chemoprevention and treatment is clearly needed for the improvement
of skin cancer care. Phytochemicals have the potential to play a role in skin cancer treatment.
First, pre-cancerous and cancerous skin lesions are readily accessible to topical agents that can
be applied only to the suspicious lesions with minimal damage to normal skin. This contrasts
with the use of phytochemical for internal organ tumors, which may require oral ingestion of the
phytochemical resulting in a systemic effect. Secondly, skin lesions and treatment efficacy can
easily be evaluated by physicians. Skin biopsies are relatively non-intrusive unlike biopsies of
tumors in internal organs. Thus, future trials evaluating the effectiveness of phytochemicals in
skin cancer could produce encouraging results.
Several promising phytochemicals have been found in a variety of fresh fruits,
vegetables, roots, and herbs, such as epigallocatechin-3-gallate, resveratrol, curcumin,
proanthocyanidins, silymarin, apigenin, capsaicin, genistein, indole-3-carbinol, and luteolin.
These compounds may contribute to cancer chemoprevention and treatment via multiple
18

mechanisms (Chau Yee Ng 2018). While these different treatments are promising, they are still
in an experimental phase, and should be regarded as such. There has been research conducted to
show they decrease susceptibility to, but no proven evidence for curing skin cancer.

Figure 10: Table of Different Fruits and Vegetables Producing Phytochemicals. Research
has been developed about the chemical pathways that can be inhibited or enhanced by
these chemicals and helps to develop treatments for cancers.
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The need for new research into treatment development for later stage skin cancer is
pressing, as in recent years, the elderly population affected by skin cancer has rapidly increased.
Aging is a risk factor for most cancers. In general, two different mechanisms have been
suggested to explain the increase of cancer risk with aging. The first explanation is the exposure
to occupational carcinogens. The second mechanism is the physical changes in the body due to
aging. Vulnerability to cancer with multiple effects of age such as disturbance of hormonal
balance, an increase of chronic proliferation and the decline in immune response with age. Skin
cancer is the most common cancer worldwide. In fact, the incidence of skin cancers is rising each
year along with the increase of an aging population. The longer life expectancy is considered
among main risk factors as well as the increased sun exposure and the ozone layer depletion.
Exposure to some chemicals such as solvents, polycyclic aromatic hydrocarbons (PAHs),
arsenics are considered risk factors for skin cancer (Atis 2015).
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Figure 11: Graph Showing Rapid Increase in Number of Skin Cancer Patients in Older
Populations Worldwide (2015-2017). Male rates almost double female rates.

The extensive background knowledge of the current understanding of skin cancer types,
as well as knowing many different risk factors leads to conclusions upon current preventative
measures. While there is no definitive cure for skin cancer, and to a further extent malignant
cancer in general, there are preventative measures people can take that are widely available to the
general public. Most people know of sunscreen, which acts as a preemptive course of action
against UV-radiation and can lessen or even prevent future risk of skin cancer. Below, more
procedural routines are discussed to prevent skin cancer, which are also widely available, but
most people may not know about.
Retinol and vitamin A derivatives play a role in cell development and differentiation,
therefore most cancers such as skin, lung, prostate, breast and ovarian appear to be suppressed by
21

retinoic acids. This study (Atis 2015) closely were geriatric patients, or the elderly population,
who make up 70% of all dermatological expenditures through Medicaid and Medicare. They are
a huge group of the overall population of skin cancer patients, so knowing their symptoms is
essential to keep current with types of skin cancers and who they affect most. This is critical in
the research for how people become susceptible to skin cancer, in showing that it is not an
immediate effect, but rather an accumulation over time that generally affects an average person
in the elderly stages of life.
Skin pigmentation is a phenotype evolved and retained over generations, primarily as
protection against harmful Ultraviolet (UV) radiations. Melanin, a light-absorbing polymer with
photochemical properties imparts color to human skin and other tissues such as hair and iris and
provides protection against UV induced damage (Gómez 2016). Variations in skin pigmentation
depend on the level and the type of melanin expressed. The two major forms of melanin
expressed in humans are eumelanin, imparting black or brown skin and hair color, and
pheomelanin, found in red hair and freckled skin. Melanin is synthesized in melanocytes in
specialized organelles called melanosomes. Transfer of the pigment to keratinocytes that
constitute the upper layers of the epidermis is essential for phenotypic manifestation of skin
pigmentation. The dendrites on melanocytes aid in the transfer of melanosomes to keratinocytes
where melanosome uptake occurs through phagocytosis (Gómez 2016).
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Figure 12: Melanin Transport System Outline. Tyrosine is taken from its initial starting
point and transport into many different cellular processes to initiate the release and
creation of melanin from the melanocyte.

Human skin responds to UV radiation exposure by increasing the expression of melanin
in skin, a pigment that protects it from UV induced damage. Melanin has a role to play in various
pigmentation disorders such as albinism, vitiligo as well as in melanoma and non-melanoma skin
cancers. A detailed understanding of the process of skin pigmentation is thus vital for
understanding the molecular pathology of these disease conditions (Terenziani 2003). Melanin
synthesis takes place in response to UV induced cues from neighboring cells such keratinocytes
and dermal fibroblasts, and exerts its protective effects when transported and expressed in
keratinocytes. Multiple roles are suggested for the protective effect of melanin in UV induced
damage. Melanin can filter UV radiation and scavenge reactive oxygen species produced as a
result of UV exposure (Raghunath 2015). The supra-nuclear cap of melanin protects cells from
DNA damage. It is reported to inhibit production of cyclobutane pyrimidine dimers and 6,4photoproducts, both of which are mutagenic. Patients with albinism have been shown to be more
susceptible to various skin cancers (Raghunath 2015).
23

Overview of Mohs Surgery
Simply using sunscreen when it is sunny outside does not always keep a person from
getting skin cancer, and that is the point to make people aware of. Physicians have been
developing techniques for years to combat skin cancer, and to date, the most effective type of
treatment is still surgical excision (SE) of the entire tumor itself. A specific technique called
Mohs surgery is discussed as the most beneficial technique to combat non-melanoma basal cell
carcinomas and leave the least amount of damage in its wake as well. One study conducted in
2016 (Nassiripour 2016) totals the vulnerable populations that were studied and compares the
cost effectiveness of Mohs surgery to the typical surgical excision used in the region. One
possible explanation for the higher cost of surgical excision compared to the Mohs surgery
method in the current study can be the fact that since the Mohs surgery has an outpatient
procedure, the costs of anesthetics, the operating room, the para clinical tests, and medical
advices before the surgery were not considered.
This difference between the costs of the Mohs and standard Surgical Excision (SE) group
can be because of the difference between physicians' visits of the two groups. The patients of the
Mohs surgery group were visited by a fellowship physician, and the patient visits of the SE
group were performed by a specialist physician, both specializing in dermatological practices. A
fellowship physician is a physician going through their residency to complete specialization,
while a specialist physician has already completed this training at an expert level (Nassiripour
2015). Typically, the fellowship visit costs are more expensive than the specialist visit costs.
Another reason for the difference between the costs of the two groups is the medication used by
the patients after their discharge. The medication given to patients by a dermatologist using
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Mohs surgery is designed to speed skin recovery after surgery which may be more expensive
than drugs prescribed by a general surgeon (Nassiripour 2015).

Figure 13: Cost-Effectiveness and Success Ratios of Mohs Surgery vs. Other Types of
Surgical Excision. Defines Mohs as the statistically most advantageous type of SE.

One study conducted in 2018 (Chen 2018) shows how Mohs Micrographic Surgery
(MMS), or Mohs surgery, is a technique used to treat skin malignancies that offers the highest
cure rates, maximally spares normal skin, and allows for the best cosmetic and functional results.
This technique consists of sequential steps that are performed on the same day in an outpatient
setting. In MMS, the Mohs surgeon also functions as the pathologist, resulting in greater
accuracy of the clinicopathology. The high cure rates in MMS are achieved through accurate
25

evaluation of 100% of the tissue margins. Thus, the Mohs surgeon's knowledge of
dermatopathology and frozen section interpretation is essential to ensure the success of this
technique.
Mohs Micrographic Surgery, a tissue-sparing technique, also produces excellent cosmetic
and functional results by allowing the surgeon to obtain adequate surgical margins to clear the
cancer prior to reconstruction. Of note, the success of MMS relies on tumor contiguity.
Noncontiguous or “skip” lesions might not be detected by MMS, thus resulting in higher
recurrence rates. Noncontinuity of lesions may occur as a result of previous treatments that failed
to completely eradicate the tumor. MMS can also be more cost effective than standard surgical
excisions. For melanoma treatment, the primary goal is complete removal with histologically
negative margins. Mohs Micrographic Surgery has been extensively used and studied for the
treatment of nonmelanoma skin cancer, particularly at sites where tissue conservation is vital
(Chen 2016).
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Figure 14: Overview of Mohs Micrographic Surgery. Summarizes the seemingly simple
process through Specialization is required for this surgery to be performed properly.

The use of MMS for melanoma treatment has yet to become widely accepted owing to
difficulties in histologic interpretation, among other factors. MMS may offer lower recurrence
rates and improved survival when compared with historical controls for standard excision.
Continued advances in MMS technique and immunohistochemical staining have allowed the
technique to gain further support.
Mohs Micrographic Surgery was originally developed in the 1930s by a general surgeon,
Dr. Frederic E. Mohs. While experimenting on skin cancer treatments as a research assistant at
the University of Wisconsin, he discovered that injecting 20% zinc chloride solution to tumors
caused tissue necrosis but preserved its microscopic architecture. He later formulated and
patented a 20% zinc chloride paste that can be applied topically on human skin (Chen 2018). He
also developed the fixed-tissue technique wherein this paste was applied on the skin cancer in
27

vivo for 24 hours prior to taking the first excision specimen. The first layer was then taken the
following day, and the specimen was processed using standard paraffin sections. If further stages
were necessary, zinc chloride was again applied overnight before the subsequent stage was
taken. Thus, it often took several days of surgery and multiple stages to achieve clear margins for
large skin cancers.

Figure 15: Image of Dr. Frederic Mohs. Developed Micrographic Mohs Surgery, which led
to great advancements in surgical precision and effectiveness against skin cancers.
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Mohs surgery has been found to be highly effective against these larger cancers, with the
range for verification of size being measured anywhere from 6mm to 20mm. The cure rates
procured in this study (Del Bino 2018) are shown to be in the range of 95% to 99% for nonmelanoma basal and squamous cell carcinomas. Based on the included guidelines, MMS is
recommended as a first-line option for high-risk primary or recurrent basal cell carcinoma. For
high-risk primary or recurrent squamous cell carcinoma, MMS may be considered as one of the
options, especially where tissue preservation or margin controls are challenging, or when the
tumor is at a critical anatomical site. For squamous cell carcinoma, MMS may be indicated for
digital and penile tumor, or in recurrent or incompletely excised lesions. MMS may also be
considered for melanoma and Merkel cell carcinoma especially when the tumor is in a sensitive
area and there are concerns of functional impairment from an excision that is too radical (Del
Bino 2018).
MMS is preferable to conventional surgery in the treatment of high-risk, recurrent, or at
critical site skin cancer. Even though the size of the lesion should be analyzed together with its
location and histological pattern, MMS could be a better treatment option for tumors larger than
2 cm which present a higher chance of incomplete removal with conventional surgery. The
review also found that MMS leads to a smaller recurrence rate than conventional surgery for
dermatofibrosarcoma protuberans, a very rare type of skin cancer that begins in the middle layer
of connective skin tissue called the dermis (Del Bino 2018).
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Figure 16: Immunostain of Dermatofibrosarcoma Protuberans. Dark band at top of stain
represents invasion of tumor into deeper layer of skin.

There are specific reasons why Mohs Micrographic Surgery is only recommended for use
on non-melanoma skin cancers. The primary concern of critics of MMS for melanoma is the
perceived inferiority of frozen sections to permanent paraffin sections in evaluating melanocytic
lesions. Part of the reason permanent sections are considered the gold standard in evaluating
melanocytic lesions is that melanocytes retain their pericytoplasmic vacuolization with this
method, allowing them to be more readily identified. In comparison, frozen sections can be
plagued by numerous artifacts caused by the freezing process, tissue folding, and keratinocyte
vacuolization resembling melanocytes which can lead to false positives. There are a variety of
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strategies to address these concerns discussed in the research literature for this matter. One
strategy to help with slide interpretation is the use of control biopsies taken from the patient’s
skin adjacent to the lesion, which serve as a measure of the patient’s background melanocytic
density. One research article (Gómez 2016) favors shallow shave biopsies harvested from both
perilesional and distant skin and also describes the use of a mapping technique which matches
subtle pigmented lesions clinically and histologically. With this mapping technique, the authors
report a reduction in the removal of Mohs layers in their clinical practice.
Another conservative strategy is to use staged excisions with rush permanent sections. In
this approach, each Mohs layer is sent for permanent paraffin sectioning, and a pathologist reads
the slides. Due to the tissue processing and evaluation time involved with this method, the
surgery is substantially prolonged and may even require several days to weeks to achieve clear
margins, hence the nickname of “slow Mohs”. Recently, one research group (Mallipeddi 2008)
described a novel 2-hour method for preparing permanent sections of MIS for MMS through
microwave tissue processing with comparable results. Despite its time-consuming nature,
permanent sectioning has long been considered the gold standard for melanocytic lesion
evaluation for the reasons previously described. However, fast and reliable
immunohistochemical stains are now increasingly being used as an adjunct to H&E-stained
frozen sections and can provide identical information to permanent sections.
Over the past few decades, the expansion in the number of immunohistochemical stains
available and the development of expedited staining protocols have led to increased utilization of
immunostaining in Mohs surgery. In addition to its use for the challenging situations previously
described, immunostaining for various tumors is useful in a variety of situations such as when
the tumor is poorly differentiated, exhibits single cell spread, tracks along nerves or vessels, or
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when pagetoid distribution is present (Albertini 2002). Regardless of the immunostain or staining
protocol used, 4-µm thin tissue sections are preferred as they provide the best staining results
without masking cellular detail (Feller 2016). Immunostaining can be applied to both permanent
and frozen sections and is performed concurrently with H&E staining. The amount of literature
regarding immunostains and staining protocols used in MMS for melanoma is so extensive that
entire review articles have been dedicated to the topic.

Discussion
The knowledge to understand each of the three main types of skin cancer can greatly
improve a patient’s outlook on their prognosis once diagnosed with skin cancer. Here, the three
main types of skin cancer are talked about in depth, specifically dealing with pathways that they
effect and what types of treatments are effective against them. Experimental treatments, such as
phytochemicals and different types of UV blockers, have shown promising results in preventing
the development of skin cancer in the most susceptible populations. While these methods can be
perfected for full effectiveness one day, there is a treatment specifically aimed at non-melanoma
skin cancers that is effective against these early stage tumors almost 100% of the time. This
method is known as Mohs Micrographic Surgery, and it provides a baseline context for how
methods in treatment against skin cancer have already been developed, as well as what is being
expanded upon for the future. Most dermatological doctors and experts today recommend this
out-patient, cost-effective surgery to anyone who wants to effectively nullify the long-term
effects a simple basal or squamous cell carcinoma can evolve when metastasizing throughout the
body.
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